ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Bioptix, Inc.
7.67
0.0000
成交量:
- -
成交額:
- -
市值:
4,144.87萬
市盈率:
-6.24
高:
7.67
開:
7.67
低:
7.67
收:
7.67
52周最高:
11.17
52周最低:
2.32
股本:
540.40萬
流通股本:
450.40萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-1.2300
淨資產收益率:
--
總資產收益率:
--
市淨率:
3.76
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字:
Bioptix, Inc.
交易所:
NASDAQ
成立時間:
- -
員工人數:
- -
公司地址:
- -
官網:
http://www.bioptix.com/
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Bioptix, Inc.致力於推進解決未滿足的人類診斷需求的產品。 Bioptix,Inc.於2000年7月24日作為科羅拉多州公司組織生產用於診斷應用的純化蛋白質。 到目前為止,該公司已利用公司的科學技術推進公司APPY1產品候選人的開發,並開發了動物健康相關資產,包括知識產權。 2012年,公司對這些動物健康相關資產進行了授權,如下所述。 公司的研究和開發活動目前主要集中在人類急性闌尾炎基於血液的測試。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BIOP/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"BIOP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOP\",,,,,undefined,":{"symbol":"BIOP","market":"US","secType":"STK","nameCN":"Bioptix, Inc.","latestPrice":7.67,"timestamp":1508356800000,"preClose":7.67,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":4503971,"shares":5404000,"eps":-1.23,"marketStatus":"退市","change":0,"latestTime":"10-18 16:00:00 EDT","open":7.67,"high":7.67,"low":7.67,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774512000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":7.67,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOP\",,,,,undefined,":{"symbol":"BIOP","floatShares":4503971,"roa":"--","roe":"--","lyrEps":0,"shares":5404000,"dividePrice":0,"high":7.67,"amplitude":0,"preClose":7.67,"low":7.67,"week52Low":2.32,"pbRate":"3.76","week52High":11.17,"institutionHeld":0,"latestPrice":7.67,"eps":-1.23,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.23,"open":7.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIOP\",params:#limit:5,,,undefined,":[{"date":"2017-10-19","symbol":"BIOP","newSymbol":"RIOT","type":"symbolChange","dateTimestamp":1508385600000},{"market":"US","date":"2017-10-12","symbol":"BIOP","amount":1,"name":"Bioptix, Inc.","currency":"USD","type":"dividend","dateTimestamp":1507780800000},{"market":"US","date":"2017-08-11","symbol":"BIOP","fiscalQuarterEnding":"2017/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1502424000000,"reportTimeType":"","actualEps":-0.21},{"market":"US","date":"2017-05-15","symbol":"BIOP","fiscalQuarterEnding":"2017/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1494820800000,"reportTimeType":"","actualEps":-0.22},{"market":"US","date":"2016-11-14","symbol":"BIOP","fiscalQuarterEnding":"2016/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1479099600000,"reportTimeType":"","actualEps":-0.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIOP\",market:\"US\",,,undefined,":[{"executeDate":"2017-10-12","recordDate":null,"paymentDate":null,"value":1,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIOP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.bioptix.com/","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0263},{"period":"1month","weight":-0.0526},{"period":"3month","weight":-0.0539},{"period":"6month","weight":-0.0074},{"period":"1year","weight":0.1378},{"period":"ytd","weight":-0.0421}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Bioptix, Inc.致力於推進解決未滿足的人類診斷需求的產品。 Bioptix,Inc.於2000年7月24日作為科羅拉多州公司組織生產用於診斷應用的純化蛋白質。 到目前為止,該公司已利用公司的科學技術推進公司APPY1產品候選人的開發,並開發了動物健康相關資產,包括知識產權。 2012年,公司對這些動物健康相關資產進行了授權,如下所述。 公司的研究和開發活動目前主要集中在人類急性闌尾炎基於血液的測試。","exchange":"NASDAQ","name":"Bioptix, Inc.","nameEN":"Bioptix, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BIOP\",market:\"US\",,,undefined,":null}}